HistCite - Chimerism and Transplantation topic search

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1	625 STARZL TE, DEMETRIS AJ, MURASE N, ILDSTAD S, RICORDI C, et al. CELL-MIGRATION, CHIMERISM, AND GRAFT ACCEPTANCE LANCET. 1992 JUN 27; 339 (8809): 1579-1582	501	819	8	45
2	4 BILLINGHAM RE, BRENT L, MEDAWAR PB ACTIVELY ACQUIRED TOLERANCE OF FOREIGN CELLS NATURE. 1953; 172 (4379): 603-606	439	2094	1	19
3	2198 Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases BLOOD. 1998 FEB 1; 91 (3): 756-763	424	1395	9	28
4	183 ILDSTAD ST, SACHS DH RECONSTITUTION WITH SYNGENEIC PLUS ALLOGENEIC OR XENOGENEIC BONE-MARROW LEADS TO SPECIFIC ACCEPTANCE OF ALLOGRAFTS OR XENOGRAFTS NATURE. 1984; 307 (5947): 168-170	379	586	4	17
5	313 SHARABI Y, SACHS DH MIXED CHIMERISM AND PERMANENT SPECIFIC TRANSPLANTATION TOLERANCE INDUCED BY A NONLETHAL PREPARATIVE REGIMEN JOURNAL OF EXPERIMENTAL MEDICINE. 1989 FEB 1; 169 (2): 493-502	363	443	6	17
6	814 STARZL TE, DEMETRIS AJ, TRUCCO M, MURASE N, RICORDI C, et al. CELL-MIGRATION AND CHIMERISM AFTER WHOLE-ORGAN TRANSPLANTATION - THE BASIS OF GRAFT ACCEPTANCE HEPATOLOGY. 1993 JUN; 17 (6): 1127-1152	357	556	17	155
7	3588 McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects BLOOD. 2001 JUN 1; 97 (11): 3390-3400	254	837	22	62
8	1179 KAWAI T, COSIMI AB, COLVIN RB, POWELSON J, EASON J, et al. MIXED ALLOGENEIC CHIMERISM AND RENAL-ALLOGRAFT TOLERANCE IN CYNOMOLGUS MONKEYS TRANSPLANTATION. 1995 JAN 27; 59 (2): 256-262	248	333	8	18
9	1977 Giralt S, Estey E, Albitar M, vanBesien K, Rondon G, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy BLOOD. 1997 JUN 15; 89 (12): 4531-4536	247	782	9	31
10	1918 Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation BLOOD. 1997 APR 15; 89 (8): 3048-3054	241	413	20	31
#	Date / Author / Journal	LCS	GCS	LCR	CR
11	340 HOROWITZ MM, GALE RP, SONDEL PM, GOLDMAN JM, KERSEY J, et al. GRAFT-VERSUS-LEUKEMIA REACTIONS AFTER BONE-MARROW TRANSPLANTATION BLOOD. 1990 FEB 1; 75 (3): 555-562	232	1717	3	30
12	1365 KOLB HJ, SCHATTENBERG A, GOLDMAN JM, HERTENSTEIN B, JACOBSEN N, et al. GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS BLOOD. 1995 SEP 1; 86 (5): 2041-2050	222	1199	10	37
13	2820 Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses BLOOD. 1999 NOV 1; 94 (9): 3234-3241	220	395	13	24
14	3004 Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment NATURE MEDICINE. 2000 APR; 6 (4): 464-469	208	298	22	35
15	2349 Khouri IF, Keating M, Korbling M, Przepiorka D, Anderlini P, et al. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies JOURNAL OF CLINICAL ONCOLOGY. 1998 AUG; 16 (8): 2817-2824	199	661	9	40
16	677 STARZL TE, DEMETRIS AJ, TRUCCO M, RAMOS H, ZEEVI A, et al. SYSTEMIC CHIMERISM IN HUMAN FEMALE RECIPIENTS OF MALE LIVERS LANCET. 1992 OCT 10; 340 (8824): 876-877	197	278	2	8
17	822 STARZL TE, DEMETRIS AJ, TRUCCO M, ZEEVI A, RAMOS H, et al. CHIMERISM AND DONOR-SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION TRANSPLANTATION. 1993 JUN; 55 (6): 1272-1277	195	273	5	31
18	1 OWEN RD IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS SCIENCE. 1945; 102 (2651): 400-401	194	918	0	6
19	2 HAMBURGER V, HAMILTON HL A SERIES OF NORMAL STAGES IN THE DEVELOPMENT OF THE CHICK EMBRYO JOURNAL OF MORPHOLOGY. 1951; 88 (1): 49-&	189	10067	0	7
20	1291 PRZEPIORKA D, WEISDORF D, MARTIN P, KLINGEMANN HG, BEATTY P, et al. CONSENSUS CONFERENCE ON ACUTE GVHD GRADING BONE MARROW TRANSPLANTATION. 1995 JUN; 15 (6): 825-828	185	1422	1	11
#	Date / Author / Journal	LCS	GCS	LCR	CR
21	1051 TOMITA Y, KHAN A, SYKES M ROLE OF INTRATHYMIC CLONAL DELETION AND PERIPHERAL ANERGY IN TRANSPLANTATION TOLERANCE INDUCED BY BONE-MARROW TRANSPLANTATION IN MICE CONDITIONED WITH A NONMYELOABLATIVE REGIMEN JOURNAL OF IMMUNOLOGY. 1994 AUG 1; 153 (3): 1087-1098	180	223	13	64
22	78 GLUCKSBE.H, STORB R, FEFER A, BUCKNER CD, NEIMAN PE, et al. CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS TRANSPLANTATION. 1974; 18 (4): 295-304	179	2146	0	56
23	1041 FONTES P, RAO AS, DEMETRIS AJ, ZEEVI A, TRUCCO M, et al. BONE-MARROW AUGMENTATION OF DONOR-CELL CHIMERISM IN KIDNEY, LIVER, HEART, AND PANCREAS ISLET TRANSPLANTATION LANCET. 1994 JUL 16; 344 (8916): 151-155	179	261	8	19
24	1989 Sykes M, Szot GL, Swenson KA, Pearson DA Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning NATURE MEDICINE. 1997 JUL; 3 (7): 783-787	178	230	13	30
25	197 ILDSTAD ST, WREN SM, BLUESTONE JA, BARBIERI SA, SACHS DH CHARACTERIZATION OF MIXED ALLOGENEIC CHIMERAS - IMMUNOCOMPETENCE, INVITRO REACTIVITY, AND GENETIC SPECIFICITY OF TOLERANCE JOURNAL OF EXPERIMENTAL MEDICINE. 1985; 162 (1): 231-244	165	231	5	23
26	1831 Collins RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation JOURNAL OF CLINICAL ONCOLOGY. 1997 FEB; 15 (2): 433-444	164	778	14	44
27	2308 Wekerle T, Sayegh MH, Hill J, Zhao Y, Chandraker A, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance JOURNAL OF EXPERIMENTAL MEDICINE. 1998 JUN 15; 187 (12): 2037-2044	164	219	15	45
28	367 KOLB HJ, MITTERMULLER J, CLEMM C, HOLLER E, LEDDEROSE G, et al. DONOR LEUKOCYTE TRANSFUSIONS FOR TREATMENT OF RECURRENT CHRONIC MYELOGENOUS LEUKEMIA IN MARROW TRANSPLANT PATIENTS BLOOD. 1990 DEC 15; 76 (12): 2462-2465	161	992	4	24
29	2674 Sykes M, Preffer F, McAfee S, Saidman SL, Weymouth D, et al. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation LANCET. 1999 MAY 22; 353 (9166): 1755-1759	159	271	12	23
30	2761 Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism TRANSPLANTATION. 1999 AUG 27; 68 (4): 480-484	159	234	22	41
#	Date / Author / Journal	LCS	GCS	LCR	CR
31	3190 Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation NEW ENGLAND JOURNAL OF MEDICINE. 2000 SEP 14; 343 (11): 750-758	157	684	10	29
32	3512 Sykes M Mixed chimerism and transplant tolerance IMMUNITY. 2001 APR; 14 (4): 417-424	156	241	46	68
33	1491 Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1996 JAN 23; 93 (2): 705-708	146	591	2	20
34	8 KAPLAN EL, MEIER P NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION. 1958; 53 (282): 457-481	145	36405	0	28
35	459 LAWLER M, HUMPHRIES P, MCCANN SR EVALUATION OF MIXED CHIMERISM BY INVITRO AMPLIFICATION OF DINUCLEOTIDE REPEAT SEQUENCES USING THE POLYMERASE CHAIN-REACTION BLOOD. 1991 JUN 1; 77 (11): 2504-2514	144	176	12	32
36	1597 Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways NATURE. 1996 MAY 30; 381 (6581): 434-438	144	1008	3	29
37	404 BARBER WH, MANKIN JA, LASKOW DA, DEIERHOI MH, JULIAN BA, et al. LONG-TERM RESULTS OF A CONTROLLED PROSPECTIVE-STUDY WITH TRANSFUSION OF DONOR-SPECIFIC BONE-MARROW IN 57 CADAVERIC RENAL-ALLOGRAFT RECIPIENTS TRANSPLANTATION. 1991 JAN; 51 (1): 70-75	139	235	0	27
38	817 STARZL TE, DEMETRIS AJ, MURASE N, THOMSON AW, TRUCCO M, et al. DONOR CELL CHIMERISM PERMITTED BY IMMUNOSUPPRESSIVE DRUGS - A NEW VIEW OF ORGAN-TRANSPLANTATION (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 217-223, 1993) IMMUNOLOGY TODAY. 1993 JUN; 14 (6): 326-332	136	202	12	53
39	257 PETZ LD, YAM P, WALLACE RB, STOCK AD, DELANGE G, et al. MIXED HEMATOPOIETIC CHIMERISM FOLLOWING BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES BLOOD. 1987 NOV; 70 (5): 1331-1337	133	178	8	43
40	350 SHARABI Y, AKSENTIJEVICH I, SUNDT TM, SACHS DH, SYKES M SPECIFIC TOLERANCE INDUCTION ACROSS A XENOGENEIC BARRIER - PRODUCTION OF MIXED RAT MOUSE LYMPHOHEMATOPOIETIC CHIMERAS USING A NONLETHAL PREPARATIVE REGIMEN JOURNAL OF EXPERIMENTAL MEDICINE. 1990 JUL 1; 172 (1): 195-202	132	206	5	34
#	Date / Author / Journal	LCS	GCS	LCR	CR
41	117 WEIDEN PL, FLOURNOY N, THOMAS ED, PRENTICE R, FEFER A, et al. ANTI-LEUKEMIC EFFECT OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF ALLOGENEIC MARROW GRAFTS NEW ENGLAND JOURNAL OF MEDICINE. 1979; 300 (19): 1068-1073	131	1030	3	31
42	98 SLAVIN S, STROBER S, FUKS Z, KAPLAN HS INDUCTION OF SPECIFIC TISSUE TRANSPLANTATION TOLERANCE USING FRACTIONATED TOTAL LYMPHOID IRRADIATION IN ADULT MICE - LONG-TERM SURVIVAL OF ALLOGENEIC BONE-MARROW AND SKIN-GRAFTS JOURNAL OF EXPERIMENTAL MEDICINE. 1977; 146 (1): 34-48	129	439	1	24
43	3446 Giralt S, Thall PF, Khouri I, Wang XM, Braunschweig I, et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation BLOOD. 2001 FEB 1; 97 (3): 631-637	128	392	6	39
44	228 COBBOLD SP, MARTIN G, QIN S, WALDMANN H MONOCLONAL-ANTIBODIES TO PROMOTE MARROW ENGRAFTMENT AND TISSUE GRAFT TOLERANCE NATURE. 1986 SEP 11; 323 (6084): 164-166	126	334	0	29
45	215 HILL RS, PETERSEN FB, STORB R, APPELBAUM FR, DONEY K, et al. MIXED HEMATOLOGIC CHIMERISM AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA IS ASSOCIATED WITH A HIGHER RISK OF GRAFT-REJECTION AND A LESSENED INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE BLOOD. 1986 MAR; 67 (3): 811-816	123	171	3	33
46	2647 Thiede C, Florek M, Bornhauser M, Ritter M, Mohr B, et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection BONE MARROW TRANSPLANTATION. 1999 MAY; 23 (10): 1055-1060	118	171	12	25
47	7227 Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, et al. Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 353-361	114	306	16	28
48	2694 Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates NATURE MEDICINE. 1999 JUN; 5 (6): 686-693	113	537	2	23
49	1347 MACKINNON S, PAPADOPOULOS EB, CARABASI MH, REICH L, COLLINS NH, et al. ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE BLOOD. 1995 AUG 15; 86 (4): 1261-1268	112	540	10	31
50	1764 Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, et al. The lost chord: Microchimerism and allograft survival IMMUNOLOGY TODAY. 1996 DEC; 17 (12): 577-584	112	187	34	78
#	Date / Author / Journal	LCS	GCS	LCR	CR
51	2023 Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong YC, et al. CTLA4-Ig and anti-CD4O ligand prevent renal allograft rejection in primates PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1997 AUG 5; 94 (16): 8789-8794	111	625	3	23
52	984 QIAN SW, DEMETRIS AJ, MURASE N, RAO AS, FUNG JJ, et al. MURINE LIVER ALLOGRAFT TRANSPLANTATION - TOLERANCE AND DONOR CELL CHIMERISM HEPATOLOGY. 1994 APR; 19 (4): 916-924	110	282	10	45
53	3123 Durham MM, Bingaman AW, Adams AB, Ha JW, Waitze SY, et al. Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning JOURNAL OF IMMUNOLOGY. 2000 JUL 1; 165 (1): 1-4	110	156	4	10
54	121 SHULMAN HM, SULLIVAN KM, WEIDEN PL, MCDONALD GB, STRIKER GE, et al. CHRONIC GRAFT VERSUS HOST SYNDROME IN MAN - A LONG-TERM CLINICOPATHOLOGIC STUDY OF 20 SEATTLE PATIENTS AMERICAN JOURNAL OF MEDICINE. 1980; 69 (2): 204-217	108	1447	1	52
55	1026 SCHLITT HJ, HUNDRIESER J, HISANAGA M, UTHOFF K, KARCK M, et al. PATTERNS OF DONOR-TYPE MICROCHIMERISM AFTER HEART-TRANSPLANTATION LANCET. 1994 JUN 11; 343 (8911): 1469-1471	108	126	4	10
56	2725 Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells SCIENCE. 1999 JUL 16; 285 (5426): 412-415	108	664	5	23
57	3554 Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell CELL. 2001 MAY 4; 105 (3): 369-377	108	1629	5	42
58	1098 KAUFMAN CL, COLSON YL, WREN SM, WATKINS S, SIMMONS RL, et al. PHENOTYPIC CHARACTERIZATION OF A NOVEL BONE-MARROW-DERIVED CELL THAT FACILITATES ENGRAFTMENT OF ALLOGENEIC BONE-MARROW STEM-CELLS BLOOD. 1994 OCT 15; 84 (8): 2436-2446	107	202	8	47
59	2412 Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype NEW ENGLAND JOURNAL OF MEDICINE. 1998 OCT 22; 339 (17): 1186-1193	107	598	11	54
60	807 STEWART FM, CRITTENDEN RB, LOWRY PA, PEARSONWHITE S, QUESENBERRY PJ LONG-TERM ENGRAFTMENT OF NORMAL AND POST-5-FLUOROURACIL MURINE MARROW INTO NORMAL NONMYELOABLATED MICE BLOOD. 1993 MAY 15; 81 (10): 2566-2571	105	248	0	19
#	Date / Author / Journal	LCS	GCS	LCR	CR
61	1765 Wood K, Sachs DH Chimerism and transplantation tolerance: Cause and effect IMMUNOLOGY TODAY. 1996 DEC; 17 (12): 584-587	105	131	21	35
62	2884 Spitzer TR, McAfee S, Sackstein R, Colby C, Multani P, et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2000; 6 (3A): 309-320	105	172	26	38
63	1323 MURASE N, STARZL TE, TANABE M, FUJISAKI S, MIYAZAWA H, et al. VARIABLE CHIMERISM, GRAFT-VERUS-HOST DISEASE, AND TOLERANCE AFTER DIFFERENT KINDS OF CELL AND WHOLE-ORGAN TRANSPLANTATION FROM LEWIS TO BROWN-NORWAY RATS TRANSPLANTATION. 1995 JUL 27; 60 (2): 158-171	104	168	31	146
64	2218 Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT BONE MARROW TRANSPLANTATION. 1998 MAR; 21 (5): 487-495	102	119	30	39
65	973 SCHLITT HJ, HUNDRIESER J, RINGE B, PICHLMAYR R DONOR-TYPE MICROCHIMERISM ASSOCIATED WITH GRAFT-REJECTION 8 YEARS AFTER LIVER-TRANSPLANTATION NEW ENGLAND JOURNAL OF MEDICINE. 1994 MAR 3; 330 (9): 646-647	101	122	3	5
66	2053 Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, et al. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys TRANSPLANTATION. 1997 SEP 15; 64 (5): 709-716	101	119	8	20
67	2202 Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma LANCET. 1998 FEB 21; 351 (9102): 559-562	101	365	2	27
68	142 WEIDEN PL, SULLIVAN KM, FLOURNOY N, STORB R, THOMAS ED ANTI-LEUKEMIC EFFECT OF CHRONIC GRAFT VERSUS HOST-DISEASE - CONTRIBUTION TO IMPROVED SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION NEW ENGLAND JOURNAL OF MEDICINE. 1981; 304 (25): 1529-1533	100	848	4	17
69	1422 BACHARLUSTIG E, RACHAMIM N, LI HW, LAN FS, REISNER Y MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE NATURE MEDICINE. 1995 DEC; 1 (12): 1268-1273	100	215	13	35
70	291 MCCUNE JM, NAMIKAWA R, KANESHIMA H, SHULTZ LD, LIEBERMAN M, et al. THE SCID-HU MOUSE - MURINE MODEL FOR THE ANALYSIS OF HUMAN HEMATOLYMPHOID DIFFERENTIATION AND FUNCTION SCIENCE. 1988 SEP 23; 241 (4873): 1632-1639	99	1040	5	43
#	Date / Author / Journal	LCS	GCS	LCR	CR
71	1024 MACKINNON S, BARNETT L, HELLER G, OREILLY RJ MINIMAL RESIDUAL DISEASE IS MORE COMMON IN PATIENTS WHO HAVE MIXED T-CELL CHIMERISM AFTER BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA BLOOD. 1994 JUN 1; 83 (11): 3409-3416	99	141	14	43
72	2911 Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DM, et al. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model JOURNAL OF CLINICAL INVESTIGATION. 2000 JAN; 105 (2): 173-181	99	120	17	37
73	4330 Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease TRANSPLANTATION. 2002 NOV 27; 74 (10): 1405-1409	96	158	23	31
74	84 THOMAS ED, STORB R, CLIFT RA, FEFER A, JOHNSON FL, et al. BONE-MARROW TRANSPLANTATION .1. NEW ENGLAND JOURNAL OF MEDICINE. 1975; 292 (16): 832-843	94	2087	0	112
75	270 SYKES M, SACHS DH MIXED ALLOGENEIC CHIMERISM AS AN APPROACH TO TRANSPLANTATION TOLERANCE IMMUNOLOGY TODAY. 1988 JAN; 9 (1): 23-27	93	130	7	41
76	279 GOLDMAN JM, GALE RP, HOROWITZ MM, BIGGS JC, CHAMPLIN RE, et al. BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - INCREASED RISK FOR RELAPSE ASSOCIATED WITH T-CELL DEPLETION ANNALS OF INTERNAL MEDICINE. 1988 JUN; 108 (6): 806-814	93	809	2	36
77	427 FERRARA JLM, DEEG HJ GRAFT-VERSUS-HOST DISEASE NEW ENGLAND JOURNAL OF MEDICINE. 1991 MAR 7; 324 (10): 667-674	93	952	3	56
78	458 SAYEGH MH, FINE NA, SMITH JL, RENNKE HG, MILFORD EL, et al. IMMUNOLOGICAL-TOLERANCE TO RENAL-ALLOGRAFTS AFTER BONE-MARROW TRANSPLANTS FROM THE SAME DONORS ANNALS OF INTERNAL MEDICINE. 1991 JUN 1; 114 (11): 954-955	93	170	2	10
79	3072 Fuchimoto Y, Huang CA, Yamada K, Shimizu A, Kitamura H, et al. Mixed chimerism and tolerance without whole body irradiation in a large animal model JOURNAL OF CLINICAL INVESTIGATION. 2000 JUN; 105 (12): 1779-1789	93	110	24	57
80	3214 Kottaridis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation BLOOD. 2000 OCT 1; 96 (7): 2419-2425	93	361	16	28
#	Date / Author / Journal	LCS	GCS	LCR	CR
81	1269 SCHARF SJ, SMITH AG, HANSEN JA, MCFARLAND C, ERLICH HA QUANTITATIVE-DETERMINATION OF BONE-MARROW TRANSPLANT ENGRAFTMENT USING FLUORESCENT POLYMERASE CHAIN-REACTION PRIMERS FOR HUMAN IDENTITY MARKERS BLOOD. 1995 APR 1; 85 (7): 1954-1963	92	134	3	22
82	1946 Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y 'Green mice' as a source of ubiquitous green cells FEBS LETTERS. 1997 MAY 5; 407 (3): 313-319	92	1496	0	15
83	571 SHARABI Y, ABRAHAM VS, SYKES M, SACHS DH MIXED ALLOGENEIC CHIMERAS PREPARED BY A NON-MYELOABLATIVE REGIMEN - REQUIREMENT FOR CHIMERISM TO MAINTAIN TOLERANCE BONE MARROW TRANSPLANTATION. 1992 MAR; 9 (3): 191-197	91	114	5	23
84	4225 Mapara MY, Kim YM, Wang SP, Bronson R, Sachs DH, et al. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells BLOOD. 2002 SEP 1; 100 (5): 1903-1909	91	145	18	26
85	1025 SUBERBIELLE C, CAILLATZUCMAN S, LEGENDRE C, BODEMER C, NOEL LH, et al. PERIPHERAL MICROCHIMERISM IN LONG-TERM CADAVERIC-KIDNEY ALLOGRAFT RECIPIENTS LANCET. 1994 JUN 11; 343 (8911): 1468-1469	90	112	6	10
86	3245 Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo NATURE MEDICINE. 2000 NOV; 6 (11): 1229-1234	90	1517	8	48
87	438 UGOZZOLI L, YAM P, PETZ LD, FERRARA GB, CHAMPLIN RE, et al. AMPLIFICATION BY THE POLYMERASE CHAIN-REACTION OF HYPERVARIABLE REGIONS OF THE HUMAN GENOME FOR EVALUATION OF CHIMERISM AFTER BONE-MARROW TRANSPLANTATION BLOOD. 1991 APR 1; 77 (7): 1607-1615	89	140	5	43
88	776 STARZL TE, DEMETRIS AJ, TRUCCO M, RICORDI C, ILDSTAD S, et al. CHIMERISM AFTER LIVER-TRANSPLANTATION FOR TYPE-IV GLYCOGEN-STORAGE-DISEASE AND TYPE-1 GAUCHERS-DISEASE NEW ENGLAND JOURNAL OF MEDICINE. 1993 MAR 18; 328 (11): 745-749	89	160	5	29
89	3347 Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2001; 7 (9): 473-485	89	130	27	39
90	336 ROY DC, TANTRAVAHI R, MURRAY C, DEAR K, GORGONE B, et al. NATURAL-HISTORY OF MIXED CHIMERISM AFTER BONE-MARROW TRANSPLANTATION WITH CD6-DEPLETED ALLOGENEIC MARROW - A STABLE EQUILIBRIUM BLOOD. 1990 JAN 1; 75 (1): 296-304	88	112	12	34
#	Date / Author / Journal	LCS	GCS	LCR	CR
91	519 MARMONT AM, HOROWITZ MM, GALE RP, SOBOCINSKI K, ASH RC, et al. T-CELL DEPLETION OF HLA-IDENTICAL TRANSPLANTS IN LEUKEMIA BLOOD. 1991 OCT 15; 78 (8): 2120-2130	87	581	4	45
92	211 ILDSTAD ST, WREN SM, BLUESTONE JA, BARBIERI SA, STEPHANY D, et al. EFFECT OF SELECTIVE T-CELL DEPLETION OF HOST AND OR DONOR BONE-MARROW ON LYMPHOPOIETIC REPOPULATION, TOLERANCE, AND GRAFT-VS-HOST DISEASE IN MIXED ALLOGENEIC CHIMERAS (B-10 + B10.D2-]B10) JOURNAL OF IMMUNOLOGY. 1986 JAN; 136 (1): 28-33	86	129	5	22
93	2519 Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, et al. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION : JOURNAL OF THE AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION. 1999 JAN; 5 (3): 133-143	86	127	0	0
94	950 PORTER DL, ROTH MS, MCGARIGLE C, FERRARA JLM, ANTIN JH INDUCTION OF GRAFT-VERSUS-HOST DISEASE AS IMMUNOTHERAPY FOR RELAPSED CHRONIC MYELOID-LEUKEMIA NEW ENGLAND JOURNAL OF MEDICINE. 1994 JAN 13; 330 (2): 100-106	85	387	11	38
95	1675 Khan A, Tomita Y, Sykes M Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen - Peripheral mechanisms do not contribute to maintenance of tolerance TRANSPLANTATION. 1996 AUG 15; 62 (3): 380-387	85	101	11	44
96	306 MAYUMI H, GOOD RA LONG-LASTING SKIN ALLOGRAFT TOLERANCE IN ADULT MICE INDUCED ACROSS FULLY ALLOGENEIC (MULTIMAJOR H-2 PLUS MULTIMINOR HISTOCOMPATIBILITY) ANTIGEN BARRIERS BY A TOLERANCE-INDUCING METHOD USING CYCLOPHOSPHAMIDE JOURNAL OF EXPERIMENTAL MEDICINE. 1989 JAN 1; 169 (1): 213-238	84	125	11	70
97	315 SCHATTENBERG A, DEWITTE T, SALDEN M, VET J, VANDIJK B, et al. MIXED HEMATOPOIETIC CHIMERISM AFTER ALLOGENEIC TRANSPLANTATION WITH LYMPHOCYTE-DEPLETED BONE-MARROW IS NOT ASSOCIATED WITH A HIGHER INCIDENCE OF RELAPSE BLOOD. 1989 APR; 73 (5): 1367-1372	82	102	10	35
98	1132 AVERSA F, TABILIO A, TERENZI A, VELARDI A, FALZETTI F, et al. SUCCESSFUL ENGRAFTMENT OF T-CELL-DEPLETED HAPLOIDENTICAL 3-LOCI INCOMPATIBLE TRANSPLANTS IN LEUKEMIA PATIENTS BY ADDITION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO BONE-MARROW INOCULUM BLOOD. 1994 DEC 1; 84 (11): 3948-3955	82	352	6	56
99	1509 Tomita Y, Sachs DH, Khan A, Sykes M Additional monoclonal antibody (mAb) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3-Gy whole body irradiation TRANSPLANTATION. 1996 FEB 15; 61 (3): 469-477	82	89	13	27
100	1948 Elwood ET, Larsen CP, Maurer MH, Routenberg KL, Neylan NF, et al. Microchimerism and rejection in clinical transplantation LANCET. 1997 MAY 10; 349 (9062): 1358-1360	82	104	14	19

Date / Author / Journal

LCS

GCS

LCR

625 STARZL TE, DEMETRIS AJ, MURASE N, ILDSTAD S, RICORDI C, et al.

CELL-MIGRATION, CHIMERISM, AND GRAFT ACCEPTANCE

LANCET. 1992 JUN 27; 339 (8809): 1579-1582

501

819

4 BILLINGHAM RE, BRENT L, MEDAWAR PB

ACTIVELY ACQUIRED TOLERANCE OF FOREIGN CELLS

NATURE. 1953; 172 (4379): 603-606

439

2094

2198 Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, et al.

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

BLOOD. 1998 FEB 1; 91 (3): 756-763

424

1395

183 ILDSTAD ST, SACHS DH

RECONSTITUTION WITH SYNGENEIC PLUS ALLOGENEIC OR XENOGENEIC BONE-MARROW LEADS TO SPECIFIC ACCEPTANCE OF ALLOGRAFTS OR XENOGRAFTS

NATURE. 1984; 307 (5947): 168-170

379

586

313 SHARABI Y, SACHS DH

MIXED CHIMERISM AND PERMANENT SPECIFIC TRANSPLANTATION TOLERANCE INDUCED BY A NONLETHAL PREPARATIVE REGIMEN

JOURNAL OF EXPERIMENTAL MEDICINE. 1989 FEB 1; 169 (2): 493-502

363

443

814 STARZL TE, DEMETRIS AJ, TRUCCO M, MURASE N, RICORDI C, et al.

CELL-MIGRATION AND CHIMERISM AFTER WHOLE-ORGAN TRANSPLANTATION - THE BASIS OF GRAFT ACCEPTANCE

HEPATOLOGY. 1993 JUN; 17 (6): 1127-1152

357

556

155

3588 McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, et al.

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

BLOOD. 2001 JUN 1; 97 (11): 3390-3400

254

837

1179 KAWAI T, COSIMI AB, COLVIN RB, POWELSON J, EASON J, et al.

MIXED ALLOGENEIC CHIMERISM AND RENAL-ALLOGRAFT TOLERANCE IN CYNOMOLGUS MONKEYS

TRANSPLANTATION. 1995 JAN 27; 59 (2): 256-262

248

333

1977 Giralt S, Estey E, Albitar M, vanBesien K, Rondon G, et al.

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy

BLOOD. 1997 JUN 15; 89 (12): 4531-4536

247

782

1918 Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, et al.

Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation

BLOOD. 1997 APR 15; 89 (8): 3048-3054

241

413

Date / Author / Journal

LCS

GCS

LCR

340 HOROWITZ MM, GALE RP, SONDEL PM, GOLDMAN JM, KERSEY J, et al.

GRAFT-VERSUS-LEUKEMIA REACTIONS AFTER BONE-MARROW TRANSPLANTATION

BLOOD. 1990 FEB 1; 75 (3): 555-562

232

1717

1365 KOLB HJ, SCHATTENBERG A, GOLDMAN JM, HERTENSTEIN B, JACOBSEN N, et al.

GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS

BLOOD. 1995 SEP 1; 86 (5): 2041-2050

222

1199

2820 Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, et al.

Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses

BLOOD. 1999 NOV 1; 94 (9): 3234-3241

220

395

3004 Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, et al.

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

NATURE MEDICINE. 2000 APR; 6 (4): 464-469

208

298

2349 Khouri IF, Keating M, Korbling M, Przepiorka D, Anderlini P, et al.

Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies

JOURNAL OF CLINICAL ONCOLOGY. 1998 AUG; 16 (8): 2817-2824

199

661

677 STARZL TE, DEMETRIS AJ, TRUCCO M, RAMOS H, ZEEVI A, et al.

SYSTEMIC CHIMERISM IN HUMAN FEMALE RECIPIENTS OF MALE LIVERS

LANCET. 1992 OCT 10; 340 (8824): 876-877

197

278

822 STARZL TE, DEMETRIS AJ, TRUCCO M, ZEEVI A, RAMOS H, et al.

CHIMERISM AND DONOR-SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION

TRANSPLANTATION. 1993 JUN; 55 (6): 1272-1277

195

273

1 OWEN RD

IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS

SCIENCE. 1945; 102 (2651): 400-401

194

918

2 HAMBURGER V, HAMILTON HL

A SERIES OF NORMAL STAGES IN THE DEVELOPMENT OF THE CHICK EMBRYO

JOURNAL OF MORPHOLOGY. 1951; 88 (1): 49-&

189

10067

1291 PRZEPIORKA D, WEISDORF D, MARTIN P, KLINGEMANN HG, BEATTY P, et al.

CONSENSUS CONFERENCE ON ACUTE GVHD GRADING

BONE MARROW TRANSPLANTATION. 1995 JUN; 15 (6): 825-828

185

1422

Date / Author / Journal

LCS

GCS

LCR

1051 TOMITA Y, KHAN A, SYKES M

ROLE OF INTRATHYMIC CLONAL DELETION AND PERIPHERAL ANERGY IN TRANSPLANTATION TOLERANCE INDUCED BY BONE-MARROW TRANSPLANTATION IN MICE CONDITIONED WITH A NONMYELOABLATIVE REGIMEN

JOURNAL OF IMMUNOLOGY. 1994 AUG 1; 153 (3): 1087-1098

180

223

78 GLUCKSBE.H, STORB R, FEFER A, BUCKNER CD, NEIMAN PE, et al.

CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS

TRANSPLANTATION. 1974; 18 (4): 295-304

179

2146

1041 FONTES P, RAO AS, DEMETRIS AJ, ZEEVI A, TRUCCO M, et al.

BONE-MARROW AUGMENTATION OF DONOR-CELL CHIMERISM IN KIDNEY, LIVER, HEART, AND PANCREAS ISLET TRANSPLANTATION

LANCET. 1994 JUL 16; 344 (8916): 151-155

179

261

1989 Sykes M, Szot GL, Swenson KA, Pearson DA

Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning

NATURE MEDICINE. 1997 JUL; 3 (7): 783-787

178

230

197 ILDSTAD ST, WREN SM, BLUESTONE JA, BARBIERI SA, SACHS DH

CHARACTERIZATION OF MIXED ALLOGENEIC CHIMERAS - IMMUNOCOMPETENCE, INVITRO REACTIVITY, AND GENETIC SPECIFICITY OF TOLERANCE

JOURNAL OF EXPERIMENTAL MEDICINE. 1985; 162 (1): 231-244

165

231

1831 Collins RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, et al.

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

JOURNAL OF CLINICAL ONCOLOGY. 1997 FEB; 15 (2): 433-444

164

778

2308 Wekerle T, Sayegh MH, Hill J, Zhao Y, Chandraker A, et al.

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

JOURNAL OF EXPERIMENTAL MEDICINE. 1998 JUN 15; 187 (12): 2037-2044

164

219

367 KOLB HJ, MITTERMULLER J, CLEMM C, HOLLER E, LEDDEROSE G, et al.

DONOR LEUKOCYTE TRANSFUSIONS FOR TREATMENT OF RECURRENT CHRONIC MYELOGENOUS LEUKEMIA IN MARROW TRANSPLANT PATIENTS

BLOOD. 1990 DEC 15; 76 (12): 2462-2465

161

992

2674 Sykes M, Preffer F, McAfee S, Saidman SL, Weymouth D, et al.

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

LANCET. 1999 MAY 22; 353 (9166): 1755-1759

159

271

2761 Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism

TRANSPLANTATION. 1999 AUG 27; 68 (4): 480-484

159

234

Date / Author / Journal

LCS

GCS

LCR

3190 Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, et al.

Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation

NEW ENGLAND JOURNAL OF MEDICINE. 2000 SEP 14; 343 (11): 750-758

157

684

3512 Sykes M

Mixed chimerism and transplant tolerance

IMMUNITY. 2001 APR; 14 (4): 417-424

156

241

1491 Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA

Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1996 JAN 23; 93 (2): 705-708

146

591

8 KAPLAN EL, MEIER P

NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION. 1958; 53 (282): 457-481

145

36405

459 LAWLER M, HUMPHRIES P, MCCANN SR

EVALUATION OF MIXED CHIMERISM BY INVITRO AMPLIFICATION OF DINUCLEOTIDE REPEAT SEQUENCES USING THE POLYMERASE CHAIN-REACTION

BLOOD. 1991 JUN 1; 77 (11): 2504-2514

144

176

1597 Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, et al.

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

NATURE. 1996 MAY 30; 381 (6581): 434-438

144

1008

404 BARBER WH, MANKIN JA, LASKOW DA, DEIERHOI MH, JULIAN BA, et al.

LONG-TERM RESULTS OF A CONTROLLED PROSPECTIVE-STUDY WITH TRANSFUSION OF DONOR-SPECIFIC BONE-MARROW IN 57 CADAVERIC RENAL-ALLOGRAFT RECIPIENTS

TRANSPLANTATION. 1991 JAN; 51 (1): 70-75

139

235

817 STARZL TE, DEMETRIS AJ, MURASE N, THOMSON AW, TRUCCO M, et al.

DONOR CELL CHIMERISM PERMITTED BY IMMUNOSUPPRESSIVE DRUGS - A NEW VIEW OF ORGAN-TRANSPLANTATION (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 217-223, 1993)

IMMUNOLOGY TODAY. 1993 JUN; 14 (6): 326-332

136

202

257 PETZ LD, YAM P, WALLACE RB, STOCK AD, DELANGE G, et al.

MIXED HEMATOPOIETIC CHIMERISM FOLLOWING BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES

BLOOD. 1987 NOV; 70 (5): 1331-1337

133

178

350 SHARABI Y, AKSENTIJEVICH I, SUNDT TM, SACHS DH, SYKES M

SPECIFIC TOLERANCE INDUCTION ACROSS A XENOGENEIC BARRIER - PRODUCTION OF MIXED RAT MOUSE LYMPHOHEMATOPOIETIC CHIMERAS USING A NONLETHAL PREPARATIVE REGIMEN

JOURNAL OF EXPERIMENTAL MEDICINE. 1990 JUL 1; 172 (1): 195-202

132

206

Date / Author / Journal

LCS

GCS

LCR

117 WEIDEN PL, FLOURNOY N, THOMAS ED, PRENTICE R, FEFER A, et al.

ANTI-LEUKEMIC EFFECT OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF ALLOGENEIC MARROW GRAFTS

NEW ENGLAND JOURNAL OF MEDICINE. 1979; 300 (19): 1068-1073

131

1030

98 SLAVIN S, STROBER S, FUKS Z, KAPLAN HS

INDUCTION OF SPECIFIC TISSUE TRANSPLANTATION TOLERANCE USING FRACTIONATED TOTAL LYMPHOID IRRADIATION IN ADULT MICE - LONG-TERM SURVIVAL OF ALLOGENEIC BONE-MARROW AND SKIN-GRAFTS

JOURNAL OF EXPERIMENTAL MEDICINE. 1977; 146 (1): 34-48

129

439

3446 Giralt S, Thall PF, Khouri I, Wang XM, Braunschweig I, et al.

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

BLOOD. 2001 FEB 1; 97 (3): 631-637

128

392

228 COBBOLD SP, MARTIN G, QIN S, WALDMANN H

MONOCLONAL-ANTIBODIES TO PROMOTE MARROW ENGRAFTMENT AND TISSUE GRAFT TOLERANCE

NATURE. 1986 SEP 11; 323 (6084): 164-166

126

334

215 HILL RS, PETERSEN FB, STORB R, APPELBAUM FR, DONEY K, et al.

MIXED HEMATOLOGIC CHIMERISM AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA IS ASSOCIATED WITH A HIGHER RISK OF GRAFT-REJECTION AND A LESSENED INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE

BLOOD. 1986 MAR; 67 (3): 811-816

123

171

2647 Thiede C, Florek M, Bornhauser M, Ritter M, Mohr B, et al.

Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

BONE MARROW TRANSPLANTATION. 1999 MAY; 23 (10): 1055-1060

118

171

7227 Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, et al.

Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression

NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 353-361

114

306

2694 Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, et al.

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

NATURE MEDICINE. 1999 JUN; 5 (6): 686-693

113

537

1347 MACKINNON S, PAPADOPOULOS EB, CARABASI MH, REICH L, COLLINS NH, et al.

ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE

BLOOD. 1995 AUG 15; 86 (4): 1261-1268

112

540

1764 Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, et al.

The lost chord: Microchimerism and allograft survival

IMMUNOLOGY TODAY. 1996 DEC; 17 (12): 577-584

112

187

Date / Author / Journal

LCS

GCS

LCR

2023 Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong YC, et al.

CTLA4-Ig and anti-CD4O ligand prevent renal allograft rejection in primates

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1997 AUG 5; 94 (16): 8789-8794

111

625

984 QIAN SW, DEMETRIS AJ, MURASE N, RAO AS, FUNG JJ, et al.

MURINE LIVER ALLOGRAFT TRANSPLANTATION - TOLERANCE AND DONOR CELL CHIMERISM

HEPATOLOGY. 1994 APR; 19 (4): 916-924

110

282

3123 Durham MM, Bingaman AW, Adams AB, Ha JW, Waitze SY, et al.

Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning

JOURNAL OF IMMUNOLOGY. 2000 JUL 1; 165 (1): 1-4

110

156

121 SHULMAN HM, SULLIVAN KM, WEIDEN PL, MCDONALD GB, STRIKER GE, et al.

CHRONIC GRAFT VERSUS HOST SYNDROME IN MAN - A LONG-TERM CLINICOPATHOLOGIC STUDY OF 20 SEATTLE PATIENTS

AMERICAN JOURNAL OF MEDICINE. 1980; 69 (2): 204-217

108

1447

1026 SCHLITT HJ, HUNDRIESER J, HISANAGA M, UTHOFF K, KARCK M, et al.

PATTERNS OF DONOR-TYPE MICROCHIMERISM AFTER HEART-TRANSPLANTATION

LANCET. 1994 JUN 11; 343 (8911): 1469-1471

108

126

2725 Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, et al.

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

SCIENCE. 1999 JUL 16; 285 (5426): 412-415

108

664

3554 Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, et al.

Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell

CELL. 2001 MAY 4; 105 (3): 369-377

108

1629

1098 KAUFMAN CL, COLSON YL, WREN SM, WATKINS S, SIMMONS RL, et al.

PHENOTYPIC CHARACTERIZATION OF A NOVEL BONE-MARROW-DERIVED CELL THAT FACILITATES ENGRAFTMENT OF ALLOGENEIC BONE-MARROW STEM-CELLS

BLOOD. 1994 OCT 15; 84 (8): 2436-2446

107

202

2412 Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, et al.

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

NEW ENGLAND JOURNAL OF MEDICINE. 1998 OCT 22; 339 (17): 1186-1193

107

598

807 STEWART FM, CRITTENDEN RB, LOWRY PA, PEARSONWHITE S, QUESENBERRY PJ

LONG-TERM ENGRAFTMENT OF NORMAL AND POST-5-FLUOROURACIL MURINE MARROW INTO NORMAL NONMYELOABLATED MICE

BLOOD. 1993 MAY 15; 81 (10): 2566-2571

105

248

Date / Author / Journal

LCS

GCS

LCR

1765 Wood K, Sachs DH

Chimerism and transplantation tolerance: Cause and effect

IMMUNOLOGY TODAY. 1996 DEC; 17 (12): 584-587

105

131

2884 Spitzer TR, McAfee S, Sackstein R, Colby C, Multani P, et al.

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2000; 6 (3A): 309-320

105

172

1323 MURASE N, STARZL TE, TANABE M, FUJISAKI S, MIYAZAWA H, et al.

VARIABLE CHIMERISM, GRAFT-VERUS-HOST DISEASE, AND TOLERANCE AFTER DIFFERENT KINDS OF CELL AND WHOLE-ORGAN TRANSPLANTATION FROM LEWIS TO BROWN-NORWAY RATS

TRANSPLANTATION. 1995 JUL 27; 60 (2): 158-171

104

168

146

2218 Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, et al.

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

BONE MARROW TRANSPLANTATION. 1998 MAR; 21 (5): 487-495

102

119

973 SCHLITT HJ, HUNDRIESER J, RINGE B, PICHLMAYR R

DONOR-TYPE MICROCHIMERISM ASSOCIATED WITH GRAFT-REJECTION 8 YEARS AFTER LIVER-TRANSPLANTATION

NEW ENGLAND JOURNAL OF MEDICINE. 1994 MAR 3; 330 (9): 646-647

101

122

2053 Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, et al.

Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys

TRANSPLANTATION. 1997 SEP 15; 64 (5): 709-716

101

119

2202 Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, et al.

Microchimerism and HLA-compatible relationships of pregnancy in scleroderma

LANCET. 1998 FEB 21; 351 (9102): 559-562

101

365

142 WEIDEN PL, SULLIVAN KM, FLOURNOY N, STORB R, THOMAS ED

ANTI-LEUKEMIC EFFECT OF CHRONIC GRAFT VERSUS HOST-DISEASE - CONTRIBUTION TO IMPROVED SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION

NEW ENGLAND JOURNAL OF MEDICINE. 1981; 304 (25): 1529-1533

100

848

1422 BACHARLUSTIG E, RACHAMIM N, LI HW, LAN FS, REISNER Y

MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE

NATURE MEDICINE. 1995 DEC; 1 (12): 1268-1273

100

215

291 MCCUNE JM, NAMIKAWA R, KANESHIMA H, SHULTZ LD, LIEBERMAN M, et al.

THE SCID-HU MOUSE - MURINE MODEL FOR THE ANALYSIS OF HUMAN HEMATOLYMPHOID DIFFERENTIATION AND FUNCTION

SCIENCE. 1988 SEP 23; 241 (4873): 1632-1639

1040

Date / Author / Journal

LCS

GCS

LCR

1024 MACKINNON S, BARNETT L, HELLER G, OREILLY RJ

MINIMAL RESIDUAL DISEASE IS MORE COMMON IN PATIENTS WHO HAVE MIXED T-CELL CHIMERISM AFTER BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

BLOOD. 1994 JUN 1; 83 (11): 3409-3416

141

2911 Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DM, et al.

Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model

JOURNAL OF CLINICAL INVESTIGATION. 2000 JAN; 105 (2): 173-181

120

4330 Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, et al.

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease

TRANSPLANTATION. 2002 NOV 27; 74 (10): 1405-1409

158

84 THOMAS ED, STORB R, CLIFT RA, FEFER A, JOHNSON FL, et al.

BONE-MARROW TRANSPLANTATION .1.

NEW ENGLAND JOURNAL OF MEDICINE. 1975; 292 (16): 832-843

2087

112

270 SYKES M, SACHS DH

MIXED ALLOGENEIC CHIMERISM AS AN APPROACH TO TRANSPLANTATION TOLERANCE

IMMUNOLOGY TODAY. 1988 JAN; 9 (1): 23-27

130

279 GOLDMAN JM, GALE RP, HOROWITZ MM, BIGGS JC, CHAMPLIN RE, et al.

BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - INCREASED RISK FOR RELAPSE ASSOCIATED WITH T-CELL DEPLETION

ANNALS OF INTERNAL MEDICINE. 1988 JUN; 108 (6): 806-814

809

427 FERRARA JLM, DEEG HJ

GRAFT-VERSUS-HOST DISEASE

NEW ENGLAND JOURNAL OF MEDICINE. 1991 MAR 7; 324 (10): 667-674

952

458 SAYEGH MH, FINE NA, SMITH JL, RENNKE HG, MILFORD EL, et al.

IMMUNOLOGICAL-TOLERANCE TO RENAL-ALLOGRAFTS AFTER BONE-MARROW TRANSPLANTS FROM THE SAME DONORS

ANNALS OF INTERNAL MEDICINE. 1991 JUN 1; 114 (11): 954-955

170

3072 Fuchimoto Y, Huang CA, Yamada K, Shimizu A, Kitamura H, et al.

Mixed chimerism and tolerance without whole body irradiation in a large animal model

JOURNAL OF CLINICAL INVESTIGATION. 2000 JUN; 105 (12): 1779-1789

110

3214 Kottaridis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, et al.

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

BLOOD. 2000 OCT 1; 96 (7): 2419-2425

361

Date / Author / Journal

LCS

GCS

LCR

1269 SCHARF SJ, SMITH AG, HANSEN JA, MCFARLAND C, ERLICH HA

QUANTITATIVE-DETERMINATION OF BONE-MARROW TRANSPLANT ENGRAFTMENT USING FLUORESCENT POLYMERASE CHAIN-REACTION PRIMERS FOR HUMAN IDENTITY MARKERS

BLOOD. 1995 APR 1; 85 (7): 1954-1963

134

1946 Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y

'Green mice' as a source of ubiquitous green cells

FEBS LETTERS. 1997 MAY 5; 407 (3): 313-319

1496

571 SHARABI Y, ABRAHAM VS, SYKES M, SACHS DH

MIXED ALLOGENEIC CHIMERAS PREPARED BY A NON-MYELOABLATIVE REGIMEN - REQUIREMENT FOR CHIMERISM TO MAINTAIN TOLERANCE

BONE MARROW TRANSPLANTATION. 1992 MAR; 9 (3): 191-197

114

4225 Mapara MY, Kim YM, Wang SP, Bronson R, Sachs DH, et al.

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

BLOOD. 2002 SEP 1; 100 (5): 1903-1909

145

1025 SUBERBIELLE C, CAILLATZUCMAN S, LEGENDRE C, BODEMER C, NOEL LH, et al.

PERIPHERAL MICROCHIMERISM IN LONG-TERM CADAVERIC-KIDNEY ALLOGRAFT RECIPIENTS

LANCET. 1994 JUN 11; 343 (8911): 1468-1469

112

3245 Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, et al.

Purified hematopoietic stem cells can differentiate into hepatocytes in vivo

NATURE MEDICINE. 2000 NOV; 6 (11): 1229-1234

1517

438 UGOZZOLI L, YAM P, PETZ LD, FERRARA GB, CHAMPLIN RE, et al.

AMPLIFICATION BY THE POLYMERASE CHAIN-REACTION OF HYPERVARIABLE REGIONS OF THE HUMAN GENOME FOR EVALUATION OF CHIMERISM AFTER BONE-MARROW TRANSPLANTATION

BLOOD. 1991 APR 1; 77 (7): 1607-1615

140

776 STARZL TE, DEMETRIS AJ, TRUCCO M, RICORDI C, ILDSTAD S, et al.

CHIMERISM AFTER LIVER-TRANSPLANTATION FOR TYPE-IV GLYCOGEN-STORAGE-DISEASE AND TYPE-1 GAUCHERS-DISEASE

NEW ENGLAND JOURNAL OF MEDICINE. 1993 MAR 18; 328 (11): 745-749

160

3347 Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, et al.

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2001; 7 (9): 473-485

130

336 ROY DC, TANTRAVAHI R, MURRAY C, DEAR K, GORGONE B, et al.

NATURAL-HISTORY OF MIXED CHIMERISM AFTER BONE-MARROW TRANSPLANTATION WITH CD6-DEPLETED ALLOGENEIC MARROW - A STABLE EQUILIBRIUM

BLOOD. 1990 JAN 1; 75 (1): 296-304

112

Date / Author / Journal

LCS

GCS

LCR

519 MARMONT AM, HOROWITZ MM, GALE RP, SOBOCINSKI K, ASH RC, et al.

T-CELL DEPLETION OF HLA-IDENTICAL TRANSPLANTS IN LEUKEMIA

BLOOD. 1991 OCT 15; 78 (8): 2120-2130

581

211 ILDSTAD ST, WREN SM, BLUESTONE JA, BARBIERI SA, STEPHANY D, et al.

EFFECT OF SELECTIVE T-CELL DEPLETION OF HOST AND OR DONOR BONE-MARROW ON LYMPHOPOIETIC REPOPULATION, TOLERANCE, AND GRAFT-VS-HOST DISEASE IN MIXED ALLOGENEIC CHIMERAS (B-10 + B10.D2-]B10)

JOURNAL OF IMMUNOLOGY. 1986 JAN; 136 (1): 28-33

129

2519 Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, et al.

Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION : JOURNAL OF THE AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION. 1999 JAN; 5 (3): 133-143

127

950 PORTER DL, ROTH MS, MCGARIGLE C, FERRARA JLM, ANTIN JH

INDUCTION OF GRAFT-VERSUS-HOST DISEASE AS IMMUNOTHERAPY FOR RELAPSED CHRONIC MYELOID-LEUKEMIA

NEW ENGLAND JOURNAL OF MEDICINE. 1994 JAN 13; 330 (2): 100-106

387

1675 Khan A, Tomita Y, Sykes M

Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen - Peripheral mechanisms do not contribute to maintenance of tolerance

TRANSPLANTATION. 1996 AUG 15; 62 (3): 380-387

101

306 MAYUMI H, GOOD RAJOURNAL OF EXPERIMENTAL MEDICINE. 1989 JAN 1; 169 (1): 213-238

125

315 SCHATTENBERG A, DEWITTE T, SALDEN M, VET J, VANDIJK B, et al.

MIXED HEMATOPOIETIC CHIMERISM AFTER ALLOGENEIC TRANSPLANTATION WITH LYMPHOCYTE-DEPLETED BONE-MARROW IS NOT ASSOCIATED WITH A HIGHER INCIDENCE OF RELAPSE

BLOOD. 1989 APR; 73 (5): 1367-1372

102

1132 AVERSA F, TABILIO A, TERENZI A, VELARDI A, FALZETTI F, et al.

SUCCESSFUL ENGRAFTMENT OF T-CELL-DEPLETED HAPLOIDENTICAL 3-LOCI INCOMPATIBLE TRANSPLANTS IN LEUKEMIA PATIENTS BY ADDITION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO BONE-MARROW INOCULUM

BLOOD. 1994 DEC 1; 84 (11): 3948-3955

352

1509 Tomita Y, Sachs DH, Khan A, Sykes M

Additional monoclonal antibody (mAb) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3-Gy whole body irradiation

TRANSPLANTATION. 1996 FEB 15; 61 (3): 469-477

100

1948 Elwood ET, Larsen CP, Maurer MH, Routenberg KL, Neylan NF, et al.

Microchimerism and rejection in clinical transplantation

LANCET. 1997 MAY 10; 349 (9062): 1358-1360

104

Chimerism and Transplantation topic search 8998 papers downloaded from Web of Science. Topic=((chimer* OR microchimer) AND (graft OR allograft* OR homograft* OR transplant*)) Timespan=1950-01-01 - 2011-12-31. Databases=SCI-EXPANDED, SSCI, A&HCI. Lemmatization=Off AND 85 papers added from the cited references list.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011
List of All Records